Sökresultat - Sun, Jong‐Mu

Förfina resultatet
  1. 1
    Adjuvant Therapy for Esophageal Squamous Cell Carcinoma

    Adjuvant Therapy for Esophageal Squamous Cell Carcinoma av Sun, Jong-Mu

    Publicerad 2020
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  2. 2
    The Effectiveness of Maintenance Pharmacotherapies for Non-Small Cell Lung Cancer

    The Effectiveness of Maintenance Pharmacotherapies for Non-Small Cell Lung Cancer av Ahn, Myung-Ju, Sun, Jong-Mu, Ahn, Jin Sock, Park, Keunchil

    Publicerad 2012
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  3. 3
    Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer

    Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer av Sun, Jong-Mu, Hwang, Deok Won, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil

    Publicerad 2013
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  4. 4
    Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib

    Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib av Kim, Youjin, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil, Sun, Jong-Mu

    Publicerad 2019
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  5. 5
    Are there any ethnic differences in the efficacy and safety of immune checkpoint inhibitors for treatment of lung cancer?

    Are there any ethnic differences in the efficacy and safety of immune checkpoint inhibitors for treatment of lung cancer? av Lee, Jiyun, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju

    Publicerad 2020
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  6. 6
    Second primary pleomorphic carcinoma arising from the pneumonectomy cavity of non-small cell lung cancer: A case report

    Second primary pleomorphic carcinoma arising from the pneumonectomy cavity of non-small cell lung cancer: A case report av Lee, Chaiyoung, Jeong, Byeong-Ho, Lee, Kyungjong, Zo, Jae Il, Sun, Jong-Mu, Choi, Yoon-La, Kim, Hojoong

    Publicerad 2021
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  7. 7
    Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis

    Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis av Byeon, Seonggyu, Ham, Jun Soo, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju

    Publicerad 2016
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  8. 8
    Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab

    Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab av Eun, Yeonghee, Kim, In Young, Sun, Jong-Mu, Lee, Jeeyun, Cha, Hoon-Suk, Koh, Eun-Mi, Kim, Hyungjin, Lee, Jaejoon

    Publicerad 2019
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  9. 9
    Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea

    Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea av Lee, Kangkook, Jung, Hyun Ae, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju

    Publicerad 2020
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  10. 10
    Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: Are They Different from Those with Common EGFR Mutations?

    Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: Are They Different from Those with Common EGFR Mutations? av Jung, Hyun Ae, Park, Sehhoon, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil

    Publicerad 2020
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  11. 11
    Comprehensive evaluation of the clinical utility of plasma EGFR test in non-small cell lung cancer patients with acquired resistance to first-line EGFR inhibitors

    Comprehensive evaluation of the clinical utility of plasma EGFR test in non-small cell lung cancer patients with acquired resistance to first-line EGFR inhibitors av Kim, Hongsik, Jung, Hyun Ae, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil, Sun, Jong-Mu

    Publicerad 2021
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  12. 12
    Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study

    Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control stu... av Lee, Ji Hyun, Lee, Ho Yun, Ahn, Myung-Ju, Park, Keunchil, Ahn, Jin Seok, Sun, Jong-Mu, Lee, Kyung Soo

    Publicerad 2016
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  13. 13
    Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model

    Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model av Ku, Bo Mi, Choi, Moon Ki, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju

    Publicerad 2018
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  14. 14
    Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea

    Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea av Kim, Hyera, Kwon, Minsuk, Kim, Binnari, Jung, Hyun Ae, Sun, Jong-Mu, Lee, Se-Hoon, Park, Keunchil, Ahn, Myung-Ju

    Publicerad 2020
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  15. 15
    The different central nervous system efficacy among gefitinib, erlotinib and afatinib in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer

    The different central nervous system efficacy among gefitinib, erlotinib and afatinib in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer av Jung, Hyun Ae, Woo, Sook Young, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil, Sun, Jong-Mu

    Publicerad 2020
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  16. 16
    Role of (18)F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis

    Role of (18)F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis av Park, Soo Bin, Park, Jung Mi, Moon, Seung Hwan, Cho, Young Seok, Sun, Jong-Mu, Kim, Byung-Tae, Lee, Kyung-Han

    Publicerad 2018
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  17. 17
    Deciphering Clinicoradiologic Phenotype for Thymidylate Synthase Expression Status in Patients with Advanced Lung Adenocarcinoma Using a Radiomics Approach

    Deciphering Clinicoradiologic Phenotype for Thymidylate Synthase Expression Status in Patients with Advanced Lung Adenocarcinoma Using a Radiomics Approach av Lee, So Won, Park, Hyunjin, Lee, Ho Yun, Sohn, Insuk, Lee, Seung-Hak, Kang, Jun, Sun, Jong-Mu, Ahn, Myung-Ju

    Publicerad 2018
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  18. 18
    Long-term Survival in Non–Small Cell Lung Cancer Patients with Metachronous Brain-Only Oligorecurrence Who Underwent Definitive Treatment

    Long-term Survival in Non–Small Cell Lung Cancer Patients with Metachronous Brain-Only Oligorecurrence Who Underwent Definitive Treatment av Kim, Hongsik, Park, Sehhoon, Jung, Hyun Ae, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju

    Publicerad 2022
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  19. 19
    Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery

    Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery av Cho, Won Kyung, Oh, Dongryul, Ahn, Yong Chan, Shim, Young Mog, Zo, Jae Ill, Sun, Jong-Mu, Ahn, Myung-Ju, Park, Keunchil

    Publicerad 2016
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  20. 20
    Mutational status of TP53 defines the efficacy of Wee1 inhibitor AZD1775 in KRAS-mutant non-small cell lung cancer

    Mutational status of TP53 defines the efficacy of Wee1 inhibitor AZD1775 in KRAS-mutant non-small cell lung cancer av Ku, Bo Mi, Bae, Yeon-Hee, Koh, Jiae, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju

    Publicerad 2017
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:

Sökverktyg: